New cell therapy shows promise for critically ill COVID-19 patients with ARDS

Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe Covid-19.

Related Keywords

New York ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Justin Stebbing ,Santa Monica ,Marc Van Dijk ,Norton Cancer Center ,Nature Communications ,Providence Saint John Health Center ,Anglia Ruskin University ,Professor Justin Stebbing ,Biomedical Sciences ,Chief Scientific Officer ,Weill Cornell Medicine ,Providence Saint John ,Health Center ,Cell ,Acute Respiratory Distress Syndrome ,Anti Inflammatory ,Dancer ,Covid 19 ,Ytokine ,Cmo ,Immunity ,Inflammation ,Embrane ,Ortality ,Pneumonia ,Research ,Espiratory ,Evere Acute Respiratory ,Yndrome ,